RAC 1.11% $1.83 race oncology ltd

Ann: Race Strategic Update August 2023, page-358

  1. 350 Posts.
    lightbulb Created with Sketch. 782
    Very sorry to hear of your personal news @Davisite, please don't rush to answer this, but I'm asking whilst it'd fresh in my mind...

    Obviously we're aware that AML is a crowded space... how well do these trial results stand out in respect of all the other AML trials which are going on?

    How well would Bisantrene stand out to a potential pharma partner relative to what could be considered competitive drugs/therapies which are at a similar stage of development?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.